Related references
Note: Only part of the references are listed.The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
Po-Ming Chow et al.
CANCER LETTERS (2020)
Bladder Cancer. Version 3.2020
Thomas W. Flaig et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification
Jae Young Hur et al.
CELLULAR ONCOLOGY (2019)
Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study
Kuan-Lin Kuo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists
Fang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
Tianlu Huang et al.
CELL DEATH & DISEASE (2019)
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
Reyaz Ur Rasool et al.
CANCER DISCOVERY (2019)
A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells
Chiara Ghezzi et al.
NATURE COMMUNICATIONS (2019)
THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism
Zhu-Jun Cheng et al.
ACTA PHARMACOLOGICA SINICA (2019)
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Juergen E. Gschwend et al.
EUROPEAN UROLOGY (2019)
Anti-tumor Drug THZ1 Suppresses TGFβ2-mediated EMT in Lens Epithelial Cells via Notch and TGFβ/Smad Signaling Pathway
Jie Ning et al.
JOURNAL OF CANCER (2019)
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Maria Rusan et al.
CANCER DISCOVERY (2018)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
Inhibition of cyclin-dependent kinase 7 suppresses human hepatocellular carcinoma by inducing apoptosis
Liqiang Zhong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Florencia Cayrol et al.
NATURE COMMUNICATIONS (2017)
Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis
Sayed Mohammad Ebrahim Sahraeian et al.
NATURE COMMUNICATIONS (2017)
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
S. A. Greenall et al.
ONCOGENESIS (2017)
Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer
Hong-Yi Kuo et al.
GLYCOBIOLOGY (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
In Papyro Comparison of TMM (edgeR), RLE (DESeq2), and MRN Normalization Methods for a Simple Two-Conditions-Without-Replicates RNA-Seq Experimental Design
Elie Maza
FRONTIERS IN GENETICS (2016)
Identification of candidate genes associated with porcine meat color traits by genome-wide transcriptome analysis
Bojiang Li et al.
SCIENTIFIC REPORTS (2016)
No Driver behind the Wheel? Targeting Transcription in Cancer
Hector L. Franco et al.
CELL (2015)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
Kyle A. Nilson et al.
MOLECULAR CELL (2015)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis
Guangchuang Yu et al.
BIOINFORMATICS (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Count-based differential expression analysis of RNA sequencing data using R and Bioconductor
Simon Anders et al.
NATURE PROTOCOLS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
Chung-Hsin Chen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer (vol 17, pg v118, 2006)
Hans von der Maase et al.
ANNALS OF ONCOLOGY (2011)
DEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Likun Wang et al.
BIOINFORMATICS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Radical cystectomy and extended pelvic lymphadenectomy: Survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only
Kenneth Steven et al.
JOURNAL OF UROLOGY (2007)
Nomograms provide improved accuracy for predicting survival after radical cystectomy
Shahrokh F. Shariat et al.
CLINICAL CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
